Strategic Diagnostics Jumps on Volume Spike

Shares of Strategic Diagnostics (SDIX) jumped 4.7% on Friday as volume surged 150% more than the 3 month daily average. There were no news or any significant events that could be detected.

Strategic Diagnostics is involved in the development, manufacture, and marketing of antibody products and analytical test kits for a range of food, water, agricultural, industrial, environmental, and scientific applications.

The company has a very tiny market cap of less than $100 million. It has about $10 million in cash and about $500 thousand in debt according to the latest Yahoo! financial data.

Shares of SDIX closed at $4.90 on Friday, which is about 10% below the 52-week high of $5.40 reached back in April.

Strategic Dianostics has made BHI's BioWatch Alert List, and will be tracked for the next two weeks.